Where does ClearPoint Neuro, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), ClearPoint Neuro, Inc. ranks #15,193 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does ClearPoint Neuro, Inc. hold?

ClearPoint Neuro, Inc. holds 19 US utility patents granted between 2021 and 2025, spanning 7 technology areas.

What is ClearPoint Neuro, Inc.'s Innovation Score?

ClearPoint Neuro, Inc. has an Innovation Score of 50.0 out of 100 (top 14% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does ClearPoint Neuro, Inc. focus on?

ClearPoint Neuro, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 18 patents, ranking #990 of 7,127 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is ClearPoint Neuro, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for ClearPoint Neuro, Inc..

What does claim depth mean for ClearPoint Neuro, Inc.'s patents?

ClearPoint Neuro, Inc.'s patents average 17.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the ClearPoint Neuro, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

ClearPoint Neuro, Inc.

USPTO PatentsView assignee record - 19 granted patents across 7 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Clearpoint ranks #15,193 of 49,997 tracked US assignees by granted-patent volume, with 19 patents across 7 technology areas.

#15,193
of 49,997 US assignees by volume: Top 14%
by Innovation Score (50.0/100): 17.2
avg claims per patent

USPTO PatentsView assignee plate

Corpus R15193 · US Corporation #15,193 · 19 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 19 grants
MID-PACK #15,193/49,997
PHOTO-FINISH Chengdu Tianma Micro-
CPC-NARROW A61B · 7 areas
INNOV-PAR 50.0/100
CLAIMS-RICH 17.2 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2021–2025 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Chengdu Tianma Micro-Electronics Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Clearpoint’s 50.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.3 pts (21%) Velocity 20.0 pts (40%) Breadth 9.4 pts (19%) Claim depth 10.3 pts (21%)

Qualcomm Incorporated · highest

85
ClearPoint Neuro · this assignee

50
3D Lighting… · lowest

7

What this shows Clearpoint's Innovation Score is 50.0/100 (top 14% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Clearpoint?

Each dot is one of Clearpoint’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Clearpoint’s own 17.2 claims/patent is ABOVE the 16.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Clearpoint vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Clearpoint's grants concentrate

ClearPoint Neuro, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 94.7% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2023 (5 grants) versus a trough of 3 in 2021. By volume, Clearpoint sits between Chengdu Tianma Micro-Electronics Co., Ltd. and Coolside Limited.

Clearpoint's three-year grant acceleration

ClearPoint Neuro, Inc. shows 12 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Chengdu Tianma Mi…

19
Cinsay

19
Circa Scientific

19
Clearflow

19
Comcast IP Holdin…

19
Con-tech Manufact…

19
Congruens Group

19
Coolside

19
Clearpoint Neuro ◀

19

What this shows ClearPoint holds 19 patents at rank #15,206, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near ClearPoint

By rank, the assignees closest to #15,206 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in ClearPoint's primary technology class.

Clearpoint's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

50 Top 14% higher than 86% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

ClearPoint Neuro, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	3	15.8%
2022	3	15.8%
2023	5	26.3%
2024	4	21.1%
2025partial year	4	21.1%

Which technologies does ClearPoint Neuro, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 18

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 9

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 6

G06T - Image Data Processing OR Generation, IN General 3

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

ClearPoint Neuro, Inc.'s patent record in context - here's where to go next.

ClearPoint Neuro, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 94.7% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #15,193 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare ClearPoint Neuro, Inc. against Chengdu Tianma Micro-Electronics Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 50.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.